Table 1.
Clinical parameters | |
IgG4-RD responder index, median (range) | 12 (6–21) |
Serum IgG (mg/dl), median (range) | 1729 (934–3593) |
Serum IgG4 (mg/dL), median (range) | 387.5 (65–2178) |
Soluble IL-2 receptor (U/mL), median (range) | 448 (202–1963) |
Atopic features | |
Past atopic history, n (%) | 17 (61%) |
Serum IgE (IU/mL), median (range) | 310 (38–3300) |
Blood eosinophil count (cells/µL), median (range) | 231 (62–1568) |
Organs involved | |
Number of affected organs, median (range) | 3 (1–6) |
Lacrimal gland and orbit, n (%) | 22 (79%) |
Salivary gland, n (%) | 19 (68%) |
Lymph node, n (%) | 16 (57%) |
Lung, n (%) | 7 (25%) |
Pancreas, n (%) | 7 (25%) |
Kidney, n (%) | 5 (18%) |
Retroperitoneum, n (%) | 3 (11%) |
Aorta, n (%) | 2 (7%) |
Skin, n (%) | 2 (7%) |
Breast, n (%) | 1 (4%) |
Paravertebral mass, n (%) | 1 (4%) |
IgG4-RD, IgG4-related disease; IL-2, interleukin-2.